Impacts to your routine care
On this page:
- If I have a flare-up for more than a couple of days, will it flag up to my consultant and will I be asked to come in for an appointment?
- Will my consultant know that I am taking part in this trial and have the data I enter on screen when I attend clinic?
- Are the usual support services still available if I have a flare-up?
If I have a flare-up for more than a couple of days, will it flag up to my consultant and will I be asked to come in for an appointment?
The data collected in the REMORA app will not be viewed or monitored by the study team or any medical team between your clinical consultations. Your collected data is shared with your rheumatology care team who will only review it at the time of your consultation.
Any change or deterioration in your condition will not be flagged up to your hospital consultant, GP or any other specialist provider or acted upon between clinical consultations. If you become unwell during the trial, it is important that you immediately seek help in the normal way.
Will my consultant know that I am taking part in this trial and have the data I enter on screen when I attend clinic?
Yes, your hospital consultant will know that you are taking part in the REMORA2 trial. If you collect symptom data using the REMORA app, this information will be available to your rheumatology care team every time you attend the clinic.
If you are invited to attend clinic by your health care professional for any extra appointments, the consultant will still be able to see the data you have collected up to that date. The consultant will only review the data at the time of your clinic appointment.
Are the usual support services still available if I have a flare?
Yes. You will continue to receive your usual treatments and attend clinical appointments as normal.
It is important for you to understand that the symptom recorded data collected in the app will not be viewed or monitored by any medical personnel between your clinical consultations. Your symptom recorded data is shared with your rheumatology care team who will only review the data at the time of your consultation. This data will not be shared with your GP or any other specialist healthcare providers.
Any change or deterioration in your condition will therefore not be identified or acted upon between clinical consultations. If you become unwell during the study it is important that you immediately seek help in the normal way.
In the Information for participants section:
Contact Us
Email: remora2@manchester.ac.uk
